Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Explore effective ways to generate income in just 5 days. Learn practical strategies that can help you boost your earnings quickly.
17,322 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
A real estate rally this year is being led by data-center REITs powering AI, pushing the sector to outsized gains eve...
A Fulton Financial director sold shares after the stock surged about 26%. This article breaks down what insider sales...
June data from the National Association of Realtors shows pending home sales fall 5.4% month over month, reflecting a...
Intel stunned investors with a triple-digit rally in early 2026. This guide breaks down why intel stock soared 278%, ...
January data show a pending home sales fall, signaling continued headwinds for buyers even as rates move modestly low...
Three well-known retailers face rising pressure as consumer spending cools and online competition intensifies. These ...
February isn’t just cold weather and bills—it's a crucial time for Medicare decisions. Retirees should double-check e...
Molson Coors shares fell sharply after a disappointing quarter and a formal downgrade from a major bank. This article...
A sharp rally in Chime Financial shares followed stronger-than-expected Q4 guidance. This piece breaks down the drive...
Nexa Lending’s Loren Riddick outlines how policy reform could reshape the HECM program, addressing reverse-to-reverse...
Two high-flying stocks with more upside may fit a patient investor's long-term plan. This article dives into NVIDIA a...